JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$251.30
가격 · 8월 20, 2026
기준 재무 정보 8월 3, 2026
52주 범위
$118–$265
91% of range
애널리스트 평점
BUY
26 analysts
목표 주가
$281
+12% upside
P/E (TTM)
-29.1
ROE
—
순이익률
—
Jazz Pharmaceuticals plc - Ordinary Shares 정보 위키백과 회사 개요
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
더 보기
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
JAZZ 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$251.29
시가총액
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
매출 (TTM)
$4.27B
배당 수익률
—
ROE
—
부채/자본
—
52주 범위
$118 – $265
JAZZ 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
JAZZ
동종업계 중앙값
P/E (TTM)
-29.1
530.6
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
JAZZ
동종업계 중앙값
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
JAZZ
동종업계 중앙값
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
JAZZ
동종업계 중앙값
Revenue YoY (매출 YoY)
4.9%
—
Revenue CAGR 3Y (매출 CAGR 3년)
5.3%
—
Revenue CAGR 5Y (매출 CAGR 5년)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (순이익 YoY)
35.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
JAZZ
동종업계 중앙값
JAZZ 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
26 명의 애널리스트
- 적극 매수 7 26.9%
- 매수 17 65.4%
- 보유 2 7.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
20 명의 애널리스트 · 2026-08-15
중앙값
$285.00
지금
$251.29
저가
$196.00
고가
$315.00
중앙값 목표
$285.00
+13.4%
평균 목표
$281.10
+11.9%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.06%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $5.71 | $6.30 | -0.59% |
| 2026년 3월 31일 | $6.34 | $4.66 | 1.7% |
| 2025년 12월 31일 | $6.64 | $6.65 | -0.01% |
| 2025년 9월 30일 | $8.13 | $6.04 | 2.1% |
| 2025년 6월 30일 | $-8.25 | $-7.76 | -0.49% |
| 2025년 3월 31일 | $1.68 | $4.75 | -3.1% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
성장률 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| 순이익 | $-356M | $560M | $415M | $-224M | $-330M |
| 희석 EPS | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 692개의 제출자 · $9.8B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 138 (+35 이전 분기 대비) | 56 (-21 이전 분기 대비) | 226 (+25 이전 분기 대비) | 191 (+13 이전 분기 대비) | -1.9M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| FMR LLC | $846,470,147 | 3,512,762 | 8.60% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731,636,247 | 3,036,213 | 7.43% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $657,763,761 | 2,729,650 | 6.68% | 주식 |
| Capital World Investors | $650,043,082 | 2,697,610 | 6.60% | 주식 |
| STATE STREET CORP | $481,895,662 | 1,999,816 | 4.89% | 주식 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394,839,917 | 1,638,544 | 4.01% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $390,196,222 | 1,619,274 | 3.96% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $297,928,728 | 1,236,065 | 3.03% | 주식 |
| AMERIPRISE FINANCIAL INC | $260,580,996 | 1,081,421 | 2.65% | 주식 |
| CITADEL ADVISORS LLC | $242,578,716 | 1,006,676 | 2.46% | 주식 |
| Swedbank AB | $233,208,837 | 967,792 | 2.37% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $184,072,164 | 763,880 | 1.87% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $165,478,678 | 686,719 | 1.68% | 주식 |
| NORGES BANK | $158,279,458 | 656,843 | 1.61% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $135,442,731 | 562,073 | 1.38% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129,891,746 | 539,037 | 1.32% | 주식 |
| Allianz Asset Management GmbH | $122,925,785 | 510,129 | 1.25% | 주식 |
| GMT Capital Corp | $109,279,895 | 453,500 | 1.11% | 주식 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105,278,106 | 436,893 | 1.07% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103,893,734 | 431,148 | 1.06% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $96,439,086 | 400,212 | 0.98% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $95,008,929 | 394,277 | 0.96% | 주식 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89,279,867 | 370,502 | 0.91% | 주식 |
| Sofinnova Investments, Inc. | $88,036,221 | 365,341 | 0.89% | 주식 |
| Polaris Capital Management, LLC | $79,270,937 | 328,966 | 0.81% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $77,695,234 | 322,427 | 0.79% | 주식 |
| Bank of New York Mellon Corp | $76,961,481 | 319,382 | 0.78% | 주식 |
| GOLDENTREE ASSET MANAGEMENT LP | $70,838,675 | 294,435 | 0.72% | 주식 |
| Qube Research & Technologies Ltd | $70,056,003 | 290,725 | 0.71% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66,815,854 | 277,279 | 0.68% | 주식 |
| Quantinno Capital Management LP | $65,906,960 | 273,506 | 0.67% | 주식 |
| Boston Trust Walden Corp | $64,110,068 | 266,050 | 0.65% | 주식 |
| BANK OF AMERICA CORP /DE/ | $60,589,497 | 251,440 | 0.62% | 주식 |
| Tri Locum Partners LP | $53,427,868 | 221,720 | 0.54% | 주식 |
| Iron Triangle Partners LP | $49,668,900 | 292,170 | 0.50% | 주식 |
| ARGENT CAPITAL MANAGEMENT LLC | $48,211,350 | 200,072 | 0.49% | 주식 |
| GOLDMAN SACHS GROUP INC | $45,527,185 | 188,933 | 0.46% | 주식 |
| PERCEPTIVE ADVISORS LLC | $40,964,900 | 170,000 | 0.42% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $39,434,259 | 163,648 | 0.40% | 주식 |
| RHUMBLINE ADVISERS | $39,282,382 | 163,018 | 0.40% | 주식 |
| Holocene Advisors, LP | $38,794,001 | 160,991 | 0.39% | 주식 |
| Saturn V Capital Management LP | $38,781,230 | 160,938 | 0.39% | 주식 |
| PFM Health Sciences, LP | $38,740,265 | 160,768 | 0.39% | 주식 |
| Retirement Systems of Alabama | $38,473,993 | 159,663 | 0.39% | 주식 |
| Woodline Partners LP | $36,165,501 | 150,083 | 0.37% | 주식 |
| LOOMIS SAYLES & CO L P | $35,355,338 | 146,721 | 0.36% | 주식 |
| Pictet Asset Management Holding SA | $35,115,175 | 147,599 | 0.36% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $34,163,762 | 141,776 | 0.35% | 주식 |
| STIFEL FINANCIAL CORP | $33,583,066 | 139,365 | 0.34% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $33,026,625 | 137,057 | 0.34% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32,383,478 | 134,388 | 0.33% | 주식 |
| California Public Employees Retirement System | $30,759,098 | 127,647 | 0.31% | 주식 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30,249,134 | 160,006 | 0.31% | 주식 |
| Robeco Institutional Asset Management B.V. | $28,340,967 | 117,612 | 0.29% | 주식 |
| Gotham Asset Management, LLC | $26,992,014 | 112,014 | 0.27% | 주식 |
| Aristotle Capital Management, LLC | $26,915,626 | 111,697 | 0.27% | 주식 |
| Swiss National Bank | $26,771,767 | 111,100 | 0.27% | 주식 |
| STOREBRAND ASSET MANAGEMENT AS | $26,309,828 | 109,183 | 0.27% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $25,928,372 | 107,600 | 0.26% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $25,286,187 | 104,935 | 0.26% | 주식 |
| BlackRock, Inc. | $23,889,284 | 99,138 | 0.24% | 주식 |
| Perpetual Ltd | $23,733,376 | 98,491 | 0.24% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $23,658,917 | 98,182 | 0.24% | 주식 |
| MORGAN STANLEY | $23,519,795 | 97,604 | 0.24% | 주식 |
| Man Group plc | $23,299,389 | 96,690 | 0.24% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22,868,053 | 94,900 | 0.23% | 풋 옵션 |
| ENVESTNET ASSET MANAGEMENT INC | $22,061,835 | 91,554 | 0.22% | 주식 |
| Rhenman & Partners Asset Management AB | $21,070,417 | 87,440 | 0.21% | 주식 |
| Aberdeen Group plc | $20,146,538 | 83,606 | 0.20% | 주식 |
| Amundi | $19,114,464 | 79,323 | 0.19% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18,916,145 | 78,500 | 0.19% | 콜 옵션 |
| Schonfeld Strategic Advisors LLC | $18,620,232 | 77,272 | 0.19% | 주식 |
| FIRST TRUST ADVISORS LP | $18,149,860 | 75,320 | 0.18% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17,765,513 | 73,725 | 0.18% | 주식 |
| LAZARD ASSET MANAGEMENT LLC | $16,768,620 | 69,588 | 0.17% | 주식 |
| Longaeva Partners L.P. | $16,576,808 | 68,792 | 0.17% | 주식 |
| Simplify Asset Management Inc. | $16,520,903 | 68,560 | 0.17% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $16,497,448 | 87,265 | 0.17% | 주식 |
| Distillate Capital Partners LLC | $16,167,159 | 67,092 | 0.16% | 주식 |
| SEB Asset Management AB | $15,890,255 | 65,943 | 0.16% | 주식 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15,380,484 | 64,700 | 0.16% | 주식 |
| SEI INVESTMENTS CO | $14,931,224 | 61,963 | 0.15% | 주식 |
| Illinois Municipal Retirement Fund | $14,911,947 | 61,883 | 0.15% | 주식 |
| Tweedy, Browne Co LLC | $14,494,105 | 60,149 | 0.15% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $14,335,788 | 59,492 | 0.15% | 주식 |
| DeepCurrents Investment Group LLC | $14,132,168 | 58,647 | 0.14% | 주식 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13,348,774 | 55,396 | 0.14% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $12,952,138 | 53,750 | 0.13% | 주식 |
| ExodusPoint Capital Management, LP | $12,819,845 | 53,201 | 0.13% | 주식 |
| Squarepoint Ops LLC | $12,807,074 | 53,148 | 0.13% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12,034,356 | 63,657 | 0.12% | 주식 |
| ALGERT GLOBAL LLC | $11,749,697 | 48,760 | 0.12% | 주식 |
| CASTLEARK MANAGEMENT LLC | $11,306,312 | 46,920 | 0.11% | 주식 |
| CITADEL ADVISORS LLC | $11,253,299 | 46,700 | 0.11% | 콜 옵션 |
| RENAISSANCE GROUP LLC | $11,221,601 | 46,568 | 0.11% | 주식 |
| Nuveen, LLC | $11,184,623 | 46,415 | 0.11% | 주식 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10,859,795 | 45,067 | 0.11% | 주식 |
| Foundry Partners, LLC | $10,730,160 | 86,429 | 0.11% | 주식 |
| Legal & General Group Plc | $10,402,916 | 43,171 | 0.11% | 주식 |
| DEAN INVESTMENT ASSOCIATES, LLC | $10,273,274 | 42,633 | 0.10% | 주식 |
회사 내부자 50 명의 내부자 · 4 임원 · 4 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 2026년 6월 30일 F | 147,361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 2026년 6월 30일 F | 56,431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 2026년 6월 30일 F | 48,871 | 0 | 2 | $-560,664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 2026년 6월 30일 F | 85,107 | 0 | 0 | $0 |
| Bryan C Cressey | 이사 | 2012년 3월 9일 S | 27,631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | 이사 | 2011년 3월 10일 A | — | 0 | 0 | $0 |
| Alexander E Albert | 이사 | 2008년 8월 15일 A | — | 0 | 0 | $0 |
| Patel Jaimin | 이사 | 2007년 8월 15일 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 2026년 8월 5일 A | 8,307 | 0 | 0 | $0 |
| Samantha Pearce | — | 2026년 8월 5일 F | 47,131 | 0 | 1 | $-1,625,977 |
| Mark Douglas Smith | — | 2026년 8월 5일 A | 11,285 | 0 | 1 | $-266,746 |
| Jennifer E. Cook | — | 2026년 8월 5일 A | 12,442 | 0 | 0 | $0 |
| Laura Hamill | — | 2026년 8월 5일 A | 8,538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 2026년 8월 5일 A | 20,054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 2026년 8월 5일 A | 1,184,633 | 0 | 0 | $0 |
| Rick E Winningham | — | 2026년 8월 5일 A | 11,172 | 0 | 2 | $-1,656,873 |
| Patrick G. Enright | — | 2026년 8월 5일 A | 22,984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 2026년 8월 5일 A | 362,287 | 0 | 20 | $-25,646,326 |
| Ted W Love | — | 2026년 8월 5일 A | 3,132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 2026년 8월 5일 A | 8,629 | 0 | 1 | $-655,680 |
| Kenneth W O'Keefe | — | 2025년 12월 2일 F | 25,811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 2019년 1월 3일 F | 16,512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 2018년 12월 14일 M | 41,184 | 0 | 0 | $0 |
| Matthew P. Young | — | 2018년 11월 23일 S | 32,068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 2018년 11월 13일 S | 24,972 | 0 | 0 | $0 |
| Paul Treacy | — | 2018년 8월 10일 S | 17,458 | 0 | 0 | $0 |
| Elmar Schnee | — | 2018년 8월 9일 A | 6,094 | 0 | 0 | $0 |
| Peter Gray | — | 2018년 8월 9일 A | 8,182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 2018년 8월 9일 A | 7,654 | 0 | 0 | $0 |
| Paul L Berns | — | 2018년 8월 9일 A | 6,772 | 0 | 0 | $0 |
| Karen J Wilson | — | 2018년 5월 11일 S | 15,757 | 0 | 0 | $0 |
| Karen L. Smith | — | 2018년 3월 5일 F | 28,474 | 0 | 0 | $0 |
| Iain Mcgill | — | 2018년 3월 5일 F | 22,048 | 0 | 0 | $0 |
| Russell J. Cox | — | 2017년 3월 6일 F | 52,795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 2015년 3월 5일 F | 38,484 | 0 | 0 | $0 |
| Fintan Keegan | — | 2014년 7월 8일 M | 31,750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 2014년 3월 5일 F | 133,387 | 0 | 0 | $0 |
| James C Momtazee | — | 2013년 8월 13일 S | 17,315 | 0 | 0 | $0 |
| Carol A Gamble | — | 2012년 3월 9일 S | 32,213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 2012년 3월 9일 S | 54,355 | 0 | 0 | $0 |
| Samuel D Colella | — | 2012년 1월 11일 M | 38,347 | 0 | 0 | $0 |
| Michael W Michelson | — | 2012년 1월 11일 M | 13,885 | 0 | 0 | $0 |
| Mark G. Eller | — | 2011년 8월 13일 M | 4,151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 2011년 8월 13일 M | 14,574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 2011년 5월 31일 J | 48,544 | 0 | 0 | $0 |
| Joan Colligan | — | 2010년 11월 30일 J | 14,424 | 0 | 0 | $0 |
| Robert M Myers | — | 2010년 11월 30일 J | 156,898 | 0 | 0 | $0 |
| James B Tananbaum | — | 2010년 8월 25일 A | 21,366 | 0 | 0 | $0 |
| Samuel R Saks | — | 2009년 1월 21일 A | 358,868 | 0 | 0 | $0 |
| Matthew K Fust | — | 2008년 11월 28일 J | 58,948 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 6 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 제출 서류 | 2014년 6월 20일 | — | 최초 제출 | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 제출 서류 | 2013년 3월 12일 | — | 최초 제출 | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 제출 서류 | 2012년 3월 14일 | — | 최초 제출 | 자본 구조 | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 제출 서류 | 2011년 9월 30일 | — | 최초 제출 | — | SEC |
| Azur Pharma Limited | 2011년 9월 28일 | — | 최초 제출 | M&A / 매각 | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 2005년 4월 28일 | — | 최초 제출 | M&A / 매각 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 72 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| IHE · iShares Trust | 3.41% | 227,668 SH | 2026년 8월 19일 | 일간 |
| PJP · Invesco Exchange-Traded Fund Trust | 2.65% | 54,916 SH | 2026년 8월 19일 | 일간 |
| PTH · Invesco Exchange-Traded Fund Trust | 1.84% | 19,113 SH | 2026년 8월 19일 | 일간 |
| PILL · Direxion Shares ETF Trust | 1.47% | 931 NS | 2026년 4월 30일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.05% | 3,468 SH | 2026년 8월 19일 | 일간 |
| RFG · Invesco Exchange-Traded Fund Trust | 1.00% | 14,155 SH | 2026년 8월 19일 | 일간 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.79% | 61,910 SH | 2026년 8월 19일 | 일간 |
| PDP · Invesco Exchange-Traded Fund Trust | 0.62% | 37,226 SH | 2026년 8월 19일 | 일간 |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.50% | 14,803 NS | 2026년 4월 30일 | N-PORT |
| ISCV · iShares Trust | 0.50% | 13,756 SH | 2026년 8월 19일 | 일간 |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.49% | 12,809 NS | 2026년 5월 31일 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.48% | 8,357 SH | 2026년 8월 19일 | 일간 |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.41% | 101,353 SH | 2026년 8월 19일 | 일간 |
| VFVA · VANGUARD WELLINGTON FUND | 0.32% | 11,363 SH | 2026년 8월 19일 | 일간 |
| VBR · VANGUARD INDEX FUNDS | 0.31% | 867,777 SH | 2026년 8월 19일 | 일간 |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.28% | 154,718 NS | 2026년 5월 31일 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.28% | 8,083 SH | 2026년 8월 19일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.25% | 169,973 NS | 2026년 4월 30일 | N-PORT |
| ISCB · iShares Trust | 0.25% | 2,808 SH | 2026년 8월 19일 | 일간 |
| MIDU · Direxion Shares ETF Trust | 0.24% | 1,006 NS | 2026년 4월 30일 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.24% | 19,561 SH | 2026년 8월 19일 | 일간 |
| IYH · iShares Trust | 0.24% | 35,143 SH | 2026년 8월 19일 | 일간 |
| NUSC · Nushares ETF Trust | 0.23% | 14,796 NS | 2026년 4월 30일 | N-PORT |
| ESML · iShares Trust | 0.22% | 25,442 SH | 2026년 8월 19일 | 일간 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.20% | 3,508 NS | 2026년 5월 31일 | N-PORT |
| SMMD · iShares Trust | 0.20% | 30,242 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.20% | 166,548 SH | 2026년 8월 19일 | 일간 |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.20% | 10,307 SH | 2026년 8월 19일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.17% | 719,903 SH | 2026년 8월 19일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.17% | 1,366,973 SH | 2026년 8월 19일 | 일간 |
| DFAT · Dimensional ETF Trust | 0.17% | 113,983 NS | 2026년 4월 30일 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.16% | 59,597 NS | 2026년 4월 30일 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.15% | 1,679 NS | 2026년 5월 31일 | N-PORT |
| IWS · iShares Trust | 0.14% | 89,222 SH | 2026년 8월 19일 | 일간 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.14% | 59 NS | 2026년 5월 31일 | N-PORT |
| WSML · iShares Trust | 0.13% | 3,473 SH | 2026년 8월 19일 | 일간 |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.13% | 2,492 NS | 2026년 5월 31일 | N-PORT |
| IWR · iShares Trust | 0.11% | 243,129 SH | 2026년 8월 19일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 3,276 SH | 2026년 8월 19일 | 일간 |
| XT · iShares Trust | 0.09% | 13,696 SH | 2026년 8월 19일 | 일간 |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.08% | 4,239 NS | 2026년 5월 31일 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.08% | 42,911 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.07% | 2,294 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.07% | 147,813 NS | 2026년 4월 30일 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.06% | 45,962 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 7,081 NS | 2026년 4월 30일 | N-PORT |
| IUSG · iShares Trust | 0.04% | 55,322 SH | 2026년 8월 19일 | 일간 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 16,406 SH | 2026년 8월 19일 | 일간 |
| IWD · iShares Trust | 0.04% | 133,701 SH | 2026년 8월 19일 | 일간 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 36,014 SH | 2026년 8월 19일 | 일간 |